|
|
fluorine F 18 FEQA The anilinoquinazoline derivative FEQA radiolabeled with the positron-emitting radioisotope fluorine F 18 with epidermal growth factor receptor (EGFR) binding and radioisotopic activities. Fluorine F 18 FEQA irreversibly binds to (EGFR), allowing imaging of EGFR-positive tumor cells with positron emission tomography (PET). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Abbreviation: | | F-18 FEQA | | | Chemical structure name: | | N-{4-[(3'- [F-18] fluoroethylphenyl)amino]-6-quinazolinyl}-acrylamide | | |
|
|